LGD-6972
L6972-01
Phase 1 small_molecule completed
Quick answer
LGD-6972 for Type 2 Diabetes Mellitus is a Phase 1 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed